AJ

Active Director Director DIN 07873478
DIN 07873478 First appointment Jul 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value •••• Premium profile

About Asha Jain

Data last updated:

Asha Jain is a Director at Le-Mantus Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Le-Mantus Pharmaceuticals Private Limited reported revenue of ₹29.31 Cr (FY 2024).

DIN 07873478
Primary Designation Director
Industry Pharma
First Appointment 13 Jul 2017
Oldest Company Age 20 yrs
Largest company Le-Mantus Pharmaceuticals Private Limited · ₹29.31 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jul 20172006₹29.31 Cr (FY 2024)Active

Board colleagues of Asha Jain

Directorship timeline

Open interactive timeline →
Le-Mantus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Asha Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asha Jain

Asha Jain currently holds 1 directorship: Le-Mantus Pharmaceuticals Private Limited (Director, since 13 Jul 2017, revenue ₹29.31 Cr (FY 2024)).

Asha Jain was first appointed on 13 Jul 2017 as Director at Le-Mantus Pharmaceuticals Private Limited.

The current boards of Asha Jain's companies include Annu Gupta (Le-Mantus Pharmaceuticals Private Limited), Ashutosh Gupta (Le-Mantus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available